Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Astrazeneca, Corvus, Curevac, Eisai, Enlivex, FSD, Harbour Biomed, Johnson & Johnson, Kancera, Kyowa Kirin, Medincell, Mei, Moderna, Regeneron, Revelation, Revive, Shanghai Junshi, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Apeiron, Bridge, Cipla, Covaxx, Dr. Reddy’s, Durect, Eiger, Enterome, Immunic, Innovent, Johnson & Johnson, Novavax, Oncimmune, Pulmatrix, Sinovac, Takeda, Viralclear.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 3D Medicines, Aim Immunotech, Algernon, Alphamab Oncology, Aslan, Astellas, Astrazeneca, Atossa, Atyr, Beigene, Clinuvel, Direct Biologics, Eli Lilly, Galera, Kyorin, Leap, Onconova, Opko Health, Rigel, Roche, Tracon.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Astrazeneca, Blade, Calliditas, Celltrion, Celularity, Corvus, Cyxone, Daiichi Sankyo, Diffusion, Eli Lilly, Humanigen, Inflarx, Kamada, Octapharma, Pfizer, Pharmabcine, Recce, Regeneron, Sinovac, Seneca, Takeda, Verona.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aerpio, Algernon, Ampio, Astrazeneca, Biophytis, Bio-Thera Solutions, Cartesian, Clear Creek, Glaxosmithkline, Hutchison China Meditech, Innovent Biologics, Lattice Biologics, Mesoblast, Novavax, Quantum Leap Healthcare, Regeneron, SAB, Sanofi, Sanofi, Transcenta.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akari, Astrazeneca, Glaxosmithkline, Mereo, Orpheris, Ovid, Redhill, Takeda, Union, Vir.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acepodia, Ascletis, Aslan, Biontech, Cynata, Novavax, Organicell Regenerative Medicine, Pfizer, Reithera, Revive, Sab, Telix Pharmaceuticals Japan, Trevena, Vanda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Ansun, Arcturus, Ascletis, Blade, Botanix, GNI Group, I-Mab, Merck, Novavax, Romark Laboratories, SAB, Syndax.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Angion Biomedica, Arch Biopartners, Bioaegis, Biontech, Cstone, Cytodyn, Eli Lilly, Enlivex, Everest Medicines, Humanigen, Idorsia, Innovent Biologics, Kamada, Ligand, Novavax, Oncolys, Pharming, Shanghai Fosun, Tessa.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AI, Ampio, Ascentage, Cerecor, Clarity, Cytodyn, Hutchison China Meditech, Immunic, Moderna, Opthea.